Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.
Medicine
{PDF} Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research: Workshop Summary Steve Olson and Adam C. Berger; Roundtable on Translating Genomic-Based Research for Health, Institute of Medicine
$9.99


![[PDF] Pan-Organizational Summit on the U.S. Science and Engineering Workforce: Meeting Summary Ph.D. Marye Anne Fox, National Academy of Sciences, National Academy of Engineering, Institute of Medicine](https://digzon.com/wp-content/uploads/2024/04/c629c79afa40d9aa1aa7cd8d213eb750-d-247x296.jpg)
![[PDF] Improving Palliative Care for Cancer National Cancer Policy Board, National Research Council, Institute of Medicine, Kathleen M. Foley, Hellen Gelband](https://digzon.com/wp-content/uploads/2024/04/247a324e47180910fba8cb4666a4c304-d-247x296.jpg)
![[PDF] On Being a Scientist: Responsible Conduct in Research, Second Edition National Academy of Sciences, National Academy of Engineering, Institute of Medicine](https://digzon.com/wp-content/uploads/2024/04/8a3bc970ab750124f6706d0bea8cc1ff-d-247x296.jpg)
![[PDF] Expanding Underrepresented Minority Participation: America's Science and Technology Talent at the Crossroads Committee on Underrepresented Groups and the Expansion of the Science and Engineering Workforce Pipeline, Engineering, and Public Policy Committee on Science, Policy and Global Affairs, National Academy of Sciences, National Academy of Engineering, Institute of Medicine](https://digzon.com/wp-content/uploads/2024/04/ac9a96ac97de7427f2198307b58fc816-d-247x296.jpg)
Reviews
There are no reviews yet.